No Data
Evercore Upgrades Bausch + Lomb Corp.(BLCO.US) to Buy Rating, Raises Target Price to $22
Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Citi Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating
Bausch + Lomb Insider Ups Holding During Year
Jefferies Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $25
Bausch + Lomb Stock Extends Gains as Jefferies Describes It as an 'Undervalued Asset'
Benjamin’s : New CEO